Spector T D, James I T, Hall G M, Thompson P W, Perrett D, Hart D J
Department of Rheumatology, St Bartholomew's Hospital Medical College, London.
Clin Rheumatol. 1993 Jun;12(2):240-4. doi: 10.1007/BF02231535.
Bone loss is a feature of RA, but the exact mechanisms involved are not clear. The collagen crosslinks deoxypyridinoline (DPYR) and pyridinoline (PYR) are specific indices of 'mature' collagen breakdown and reflect increased bone turnover. The aims of the study were to examine crosslink levels in RA and their association with disease activity and the effect of steroids. Urinary crosslinks corrected for creatinine were measured on morning fasting samples by HPLC in 70 postmenopausal women with rheumatoid arthritis (RA) aged 45-65 and compared with 169 postmenopausal healthy age-matched controls from the population. Mean levels of PYR were significantly higher in RA cases than in controls (52.4 versus 37.5 nmols/mmolCr) although mean levels of DPYR did not differ significantly. A weak correlation was found with ESR and PYR (r = 0.35) but not with other markers of disease activity. Thirteen of the RA cases were current steroid users and their levels of DPYR and PYR even with low doses, were significantly elevated above those of non-users, ex-users and controls. The finding of raised urinary PYR but not the bone specific DPYR in nonsteroid using RA cases suggests that the increased collagen breakdown does not primarily come from bone but from other sources such as cartilage and synovium. The large increases in collagen excretion in low dose steroid users, may reflect the higher risk of osteoporosis in this group.
骨质流失是类风湿关节炎(RA)的一个特征,但具体机制尚不清楚。胶原蛋白交联物脱氧吡啶啉(DPYR)和吡啶啉(PYR)是“成熟”胶原蛋白分解的特定指标,反映了骨转换增加。本研究的目的是检测RA患者的交联水平及其与疾病活动的关系以及类固醇的影响。通过高效液相色谱法(HPLC)对70名年龄在45 - 65岁的绝经后类风湿关节炎(RA)女性患者早晨空腹样本中校正肌酐后的尿交联物进行测量,并与169名来自该人群的年龄匹配的绝经后健康对照者进行比较。RA患者的PYR平均水平显著高于对照组(52.4对37.5 nmol/mmolCr),而DPYR的平均水平无显著差异。发现ESR与PYR之间存在弱相关性(r = 0.35),但与其他疾病活动标志物无相关性。13例RA患者正在使用类固醇,即使是低剂量,他们的DPYR和PYR水平也显著高于未使用者、已停用者和对照组。在未使用类固醇的RA患者中发现尿PYR升高但骨特异性DPYR未升高,这表明胶原蛋白分解增加并非主要源于骨骼,而是来自软骨和滑膜等其他来源。低剂量类固醇使用者胶原蛋白排泄大幅增加,可能反映了该组骨质疏松风险较高。